Almirall, S.A. (ALM.MC) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Spain, listed on MCE. Market cap 2.20B EUR. 52-week range 10.02 to 13.98 EUR. Trailing P/E 30.7. Data as of 2026-10-09.
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary system and sex hormones, ...